RB but not R-HCVAD is a feasible induction regimen prior to auto-HCT in frontline MCL: results of SWOG Study S1106

Aggressive induction chemotherapy followed by autologous haematopoietic stem cell transplant (auto-HCT) is effective for younger patients with mantle cell lymphoma (MCL). However, the optimal induction regimen is widely debated. The Southwesterm Oncology Group S1106 trial was designed to assess ritu...

詳細記述

保存先:
書誌詳細
出版年:Br J Haematol
主要な著者: Chen, Robert W., Li, Hongli, Bernstein, Steven H., Kahwash, Samir, Rimsza, Lisa M., Forman, Stephen J., Constine, Louis, Shea, Thomas C., Cashen, Amanda F., Blum, Kristie A., Fenske, Timothy S., Barr, Paul M., Phillips, Tycel, Leblanc, Michael, Fisher, Richard I., Cheson, Bruce D., Smith, Sonali M., Faham, Malek, Wilkins, Jennifer, Leonard, John P., Kahl, Brad S., Friedberg, Jonathan W.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318240/
https://ncbi.nlm.nih.gov/pubmed/27992063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14480
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料